Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Dose Dense

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial

Annals of Oncology ◽

10.1093/annonc/mdx772 ◽

2018 ◽

Vol 29 (3) ◽

pp. 661-668 ◽

Cited By ~ 1

Author(s):

A. Gennari ◽

Z. Sun ◽

U. Hasler-Strub ◽

M. Colleoni ◽

M.J. Kennedy ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

Maintenance Schedules ◽

First Line Treatment

A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer

Annals of Oncology ◽

10.1093/annonc/mdg111 ◽

2003 ◽

Vol 14 (3) ◽

pp. 433-440 ◽

Cited By ~ 13

Author(s):

R. Paridaens ◽

F. Van Aelst ◽

V. Georgoulias ◽

H. Samonnig ◽

V. Cocquyt ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2011.03.019 ◽

2011 ◽

Vol 11 (4) ◽

pp. 211-220 ◽

Cited By ~ 23

Author(s):

Adam Brufsky ◽

Karen Hoelzer ◽

Thaddeus Beck ◽

Robert Whorf ◽

Mark Keaton ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer

Breast Cancer Research ◽

10.1186/bcr3661 ◽

2014 ◽

Vol 16 (3) ◽

Cited By ~ 30

Author(s):

Edith A Perez ◽

Sara A Hurvitz ◽

Lukas C Amler ◽

Kirsten E Mundt ◽

Vivian Ng ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Trastuzumab Emtansine ◽

Her2 Expression ◽

First Line ◽

Her2 Positive ◽

Randomized Phase Ii

A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer

Annals of Oncology ◽

10.1093/annonc/mdh107 ◽

2004 ◽

Vol 15 (3) ◽

pp. 433-439 ◽

Cited By ~ 28

Author(s):

S. Cresta ◽

G. Grasselli ◽

M. Mansutti ◽

A. Martoni ◽

G. Lelli ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Randomized phase II study ofnab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer

Cancer Science ◽

10.1111/cas.13221 ◽

2017 ◽

Vol 108 (5) ◽

pp. 987-994 ◽

Cited By ~ 7

Author(s):

Kenji Tamura ◽

Kenichi Inoue ◽

Norikazu Masuda ◽

Shintaro Takao ◽

Masahiro Kashiwaba ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Randomized phase II study of weekly versus every 3 week ixabepilone plus bevacizumab (ixa/bev) versus paclitaxel plus bev (pac/bev) as first-line therapy for metastatic breast cancer (MBC): Final results.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1040 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1040-1040 ◽

Cited By ~ 10

Author(s):

H. S. Rugo ◽

M. Campone ◽

D. Amadori ◽

A. M. Wardley ◽

D. Aldrighetti ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.1044 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 1044-1044 ◽

Cited By ~ 1

Author(s):

Saverio Cinieri ◽

Arlene Chan ◽

Kadri Altundag ◽

Ann Vandebroek ◽

Nicole Tubiana-Mathieu ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study

Clinical Breast Cancer ◽

10.3816/cbc.2010.n.041 ◽

2010 ◽

Vol 10 (4) ◽

pp. 313-317 ◽

Cited By ~ 3

Author(s):

Juan de la Haba-Rodriguez ◽

Rosario González Mancha ◽

Gumersindo Pérez Manga ◽

Enrique Aranda Aguilar ◽

José Manuel Baena Cañada ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Annals of Oncology ◽

10.1093/annonc/mdx505 ◽

2018 ◽

Vol 29 (1) ◽

pp. 154-161 ◽

Cited By ~ 70

Author(s):

H.S. Han ◽

V. Diéras ◽

M. Robson ◽

M. Palácová ◽

P.K. Marcom ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Randomized Phase Ii ◽

Locally Recurrent